肝脏 ›› 2021, Vol. 26 ›› Issue (10): 1057-1068.

• 指南与共识 •    下一篇

HBV/HCV相关肝细胞癌抗病毒治疗专家共识(2021年更新版)

中华医学会肝病学分会肝癌学组   

  • 收稿日期:2021-08-26 出版日期:2021-10-31 发布日期:2021-12-07
  • 通讯作者: 牛俊奇,junqiniu@aliyun.com,吉林大学第一医院;江家骥,Doctorjjj@sina.cn,福建医科大学附属第一医院;叶胜龙,slye@shmu.edu.cn,复旦大学附属中山医院,海军军医大学东方肝胆外科医院

Expert consensus on antiviral therapy for HBV/HCV-related hepatocellular carcinoma:A 2021 update

Liver Cancer Study Group,Chinese Society of Hepatology,Chinese Medical Association   

  • Received:2021-08-26 Online:2021-10-31 Published:2021-12-07

摘要: 随着抗HBV、HCV 治疗学的进展,中华医学会肝病学分会肝癌学组组织相关领域专家对《HBV/ HCV 相关肝细胞癌抗病毒治疗专家共识》进行了更新。此版共识在以往专家建议/ 共识基础上,对近年新证据结果进行分析并形成相关推荐意见,以期为肝病专科、感染科以及这些科室以外从事与肝癌诊疗工作相关的临床医生及社区服务中心、基层医疗机构等相关工作人员提供指导和参考。

关键词: 乙型肝炎病毒, 丙型肝炎病毒, 肝细胞癌, 治疗学, 共识

Abstract: With the development of anti-HBV and HCV therapy,experts in related fields organized by the Liver Cancer Study Group,Chinese Society of Hepatology,Chinese Medical Association updated “Experts Consensus on Antiviral Therapy for HBV/ HCV-related Hepato-cellular Carcinoma”.On the basis of previous expert recommendations/ consensus and the new evidence in recent years,this new consensus was developed,and the relevant recommendations are provided to hepatologists,epidemiologists,medical doctors and specialists working in community service centers and primary health care institutions for guidance of hepatocellular carcinoma antiviral treatment.

Key words: Hepatitis B Virus, Hepatitis C Virus, Hepatocellular Carcinoma, Therapeutics, Consensus